Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted benzoazole PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders

Substituted benzoazole PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders

US Patent 8883833 · Granted Nov 11, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating neurodegenerative disease with substituted n-hexanoic-l-tyro2025
Hydrazide containing nuclear transport modulators and uses thereof2025
Heteroaryl inhibitors of PDE42025
Inhibitors of DUX4 induction for regulation of muscle function2023
Hydrazide containing nuclear transport modulators and uses thereof2023
Heteroaryl inhibitors of PDE42023
Method of identifying potential inhibitors of APO TNFα trimers2023
Heteroaryl inhibitors of PDE42022
Generation of muscle lineage cells and therapeutic uses thereof2022
Nuclear transport modulators and uses thereof2022
PDE4D inhibitors2021
Inhibitors of DUX4 induction for regulation of muscle function2021